ARMACEUTICA, INC.

Capabilities

Pharmaceutical company developing a cancer drug. The drug, Pyronaridine or PND, is a small-molecule and is approved by health regulatory authorities to treat malaria. The company is repurposing PND to treat various types of cancer; including leukemia, lymphoma, multiple myeloma, melanoma, glioblastoma, prostate, breast and lung. The company has received patents from the US, EU, Japan and other countries. The advantage of the drug is that it is essentially free from the serious side-effects associated with other chemotherapies.